5-Chloroimidazo[1,2-a]pyridine hydrochloride
95%
- Product Code: 120045
CAS:
3931-68-8
| Molecular Weight: | 189.04 g./mol | Molecular Formula: | C₇H₆Cl₂N₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly as an intermediate in the synthesis of various biologically active molecules. Its structure is valuable in creating compounds that target specific receptors or enzymes, making it useful in the development of potential drugs for treating neurological disorders, infections, or inflammatory conditions. Additionally, it may serve as a building block in medicinal chemistry for designing and optimizing drug candidates with improved efficacy and safety profiles.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿2,620.00 |
+
-
|
| 1.000 | 10-20 days | ฿6,300.00 |
+
-
|
5-Chloroimidazo[1,2-a]pyridine hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly as an intermediate in the synthesis of various biologically active molecules. Its structure is valuable in creating compounds that target specific receptors or enzymes, making it useful in the development of potential drugs for treating neurological disorders, infections, or inflammatory conditions. Additionally, it may serve as a building block in medicinal chemistry for designing and optimizing drug candidates with improved efficacy and safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :